Current Perspectives on HER2 Testing: A Review of National Testing Guidelines

Michael Bilous(Western Sydney University), Marc J. van de Vijver(The Netherlands Cancer Institute)
Modern Pathology
February 1, 2003
10.1097/01.mp.0000052102.90815.82
Cited by 269

Related Papers

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The landscape of cancer genes and mutational processes in breast cancer
|Nature|2012|1.7k
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial
|The Lancet Oncology|2011|369
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
|British Journal of Cancer|2003|316
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
|The Lancet Oncology|2007|278